Target Name: MIR654
NCBI ID: G724024
Review Report on MIR654 Target / Biomarker Content of Review Report on MIR654 Target / Biomarker
MIR654
Other Name(s): MIRN654 | microRNA 654 | hsa-mir-654 | MicroRNA 654 | hsa-miR-654-3p | mir-654 | hsa-miR-654-5p

MIR654: A Potential Drug Target and Biomarker

MIR654, also known as MIRN654, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. MIR654 is a small molecule that can interact with several nuclear proteins, including nuclear export proteins. Nuclear export proteins are involved in the export of various molecules from the nucleus to the cytoplasm, including proteins involved in cell signaling pathways, metabolism, and stress responses. MIR654 has been shown to play a role in regulating the export of these proteins, which may have implications for the functions of various cellular processes.

One of the unique features of MIR654 is its ability to form a stable complex with certain nuclear export proteins. This stability has been shown to play a role in the regulation of protein export, and may be a potential target for small molecules that can inhibit or modulate this process. In addition, MIR654 has been shown to interact with the protein known as p16INK4a, which is a known regulator of nuclear export. This interaction may suggest a potential role for MIR654 in the regulation of protein export, including the export of proteins involved in cell signaling pathways.

Another potential mechanism by which MIR654 may be involved in the regulation of protein export is its role in the regulation of microRNA (miRNA) expression. miRNAs are small non-coding RNAs that play a critical role in post-transcriptional gene regulation by binding to specific target mRNAs. MIR654 has been shown to interact with the miRNA-containing protein known as sarcosomal RNA (SRRNA), which is a component of the endoplasmic reticulum (ER). This interaction may suggest a potential role for MIR654 in the regulation of miRNA expression, including the export of miRNAs involved in cell signaling pathways.

In addition to its potential role in the regulation of protein export, MIR654 may also be involved in the regulation of gene expression. MIR654 has been shown to interact with the protein known as HIF1伪, which is a known regulator of oxygen homeostasis and gene expression. This interaction may suggest a potential role for MIR654 in the regulation of gene expression, including the expression of genes involved in cell signaling pathways.

MIR654 has also been shown to play a role in the regulation of cellular processes such as cell division, apoptosis, and inflammation. MIR654 has been shown to interact with the protein known as p21, which is a known regulator of the T-cell signaling pathway. This interaction may suggest a potential role for MIR654 in the regulation of cell division and apoptosis, including the regulation of the T-cell signaling pathway. In addition, MIR654 has been shown to interact with the protein known as NF-kappa-B, which is a known regulator of inflammation and cellular processes. This interaction may suggest a potential role for MIR654 in the regulation of inflammation and cellular processes.

In conclusion, MIR654 is a non-coding RNA molecule that has been shown to play a role in regulating the export of nuclear proteins, the regulation of miRNA expression, and the regulation of gene expression. These findings suggest MIR654 may be a potential drug target and biomarker for a variety of cellular processes. Further research is needed to fully understand the functions of MIR654 and its potential implications for cellular processes.

Protein Name: MicroRNA 654

The "MIR654 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR654 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793